BYTES

Proposed IPR law raises concerns

Ranbaxy settles patent row out of court

"Farmers' wisdom must be on paper in era of patents"

Scientists' interest v the public's

Basic Instinct

In a simultaneous press release issued on Monday, 26 June 2000, the Human Genome Project, an international government-funded project, and Celera …

High on broth, low on geography

Geographical indication tags are being handed out indiscriminately—with no strategy

Meeting in vain

The fifth conference on biological diversity held recently in Nairobi ended on a flat note

PATENT TROUBLES

Double standards

The US government procures generic drugs for anthrax from a non-patent holder

Sans safeguards?

The newly amended patents bill is replete with loopholes

Unity in diversity

Young scientists in Kolkata make leather out of fish skin

College duo comes up with eco-friendly tanning process

Novartis loses patent battle

No hair-raising experience this

A promise of equitable access to all

WHO, pharma giants and governments have come together to provide access to all on COVID-19 therapies. But will WIPO allow this to happen?

Trans Pacific squeeze

The Trans Pacific Partnership is a mega trade deal that closes the doors for India's trade options

IPR course in school? It's silly

Promoting the study of intellectual property rights without focusing on innovation is so misplaced that it's laughable

A deadly virus of patenting

A Dutch institute's patent application on the MERS virus raises concerns about public health

Profit at any cost

The US drug companies want to maintain its monopoly over drug pricing -- a move that will delay the production of cheaper drugs

The battle for knowledge

What are patents? Why have they become politically contentious and a major source of friction between rich nations and the developing world?

Sinking planks

Phytoplankton production could damage oceanic ecosystems

A fine balance

The bill keeps national interests intact and remains TRIPS compliant

Prescription for relief

News for farmers